trihexyphenidyl has been researched along with Paralysis in 2 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
Paralysis: A general term most often used to describe severe or complete loss of muscle strength due to motor system disease from the level of the cerebral cortex to the muscle fiber. This term may also occasionally refer to a loss of sensory function. (From Adams et al., Principles of Neurology, 6th ed, p45)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Muscettola, GB | 1 |
| Giovannucci, M | 1 |
| Montanini, R | 1 |
| Morselli, PL | 1 |
| Garattini, S | 1 |
| Abenson, MH | 1 |
2 other studies available for trihexyphenidyl and Paralysis
| Article | Year |
|---|---|
Relationship between desipramine plasma levels and the effect in Parkinson's syndrome.
Topics: Adult; Aged; Contracture; Desipramine; Drug Synergism; Female; Humans; Male; Middle Aged; Paralysis; | 1972 |
Chlorimipramine in the treatment of severe depression.
Topics: Depression; Dibenzazepines; Female; Humans; Middle Aged; Paralysis; Trihexyphenidyl | 1971 |